A recent article in the Wall Street Journal (WSJ) is calling attention to the topic of self-referral, an issue that has irked laboratories for years. The article, published Oct. 22, 2014, highlights a program used at 21st Century Oncology Holdings Inc.—a national chain of cancer practices—that gives its urologist a financial incentive to order fluorescence…

This content is for Paid Members only.
Login Register